Alkeran

In the US, Alkeran (melphalan systemic) is a member of the drug class alkylating agents and is used to treat Multiple Myeloma and Ovarian Cancer.

US matches:

Ingredient matches for Alkeran

Melphalan

Melphalan is reported as an ingredient of Alkeran in the following countries:

  • Australia
  • Austria
  • Bahrain
  • Belgium
  • Brazil
  • Canada
  • China
  • Czech Republic
  • Denmark
  • Egypt
  • Ethiopia
  • Finland
  • Germany
  • Greece
  • Hong Kong
  • Iceland
  • India
  • Iran
  • Iraq
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kenya
  • Kuwait
  • Latvia
  • Lebanon
  • Lithuania
  • Luxembourg
  • Malaysia
  • Mexico
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Philippines
  • Poland
  • Portugal
  • Qatar
  • Romania
  • Russian Federation
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Sweden
  • Switzerland
  • Syria
  • Taiwan
  • Thailand
  • Turkey
  • United Arab Emirates
  • United Kingdom
  • United States
  • Yemen

Melphalan hydrochloride (a derivative of Melphalan) is reported as an ingredient of Alkeran in the following countries:

  • Chile
  • Lithuania
  • Sweden
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here

Close
Hide
(web4)